188 related articles for article (PubMed ID: 11067653)
1. Antiviral therapies for herpes zoster infections. Are they economically justifiable?
Smith KJ; Roberts MS
Pharmacoeconomics; 2000 Aug; 18(2):95-104. PubMed ID: 11067653
[TBL] [Abstract][Full Text] [Related]
2. Cost effectiveness of newer antiviral agents for herpes zoster: is the evidence spotty?
Smith KJ; Roberts MS
J Infect Dis; 1998 Nov; 178 Suppl 1():S85-90. PubMed ID: 9852982
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.
Pellissier JM; Brisson M; Levin MJ
Vaccine; 2007 Nov; 25(49):8326-37. PubMed ID: 17980938
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of vaccination of the elderly against herpes zoster in The Netherlands.
de Boer PT; Pouwels KB; Cox JM; Hak E; Wilschut JC; Postma MJ
Vaccine; 2013 Feb; 31(9):1276-83. PubMed ID: 23306360
[TBL] [Abstract][Full Text] [Related]
5. Cost effectiveness of herpes zoster vaccine in Canada.
Najafzadeh M; Marra CA; Galanis E; Patrick DM
Pharmacoeconomics; 2009; 27(12):991-1004. PubMed ID: 19908924
[TBL] [Abstract][Full Text] [Related]
6. Antiviral therapy of acute herpes zoster in older patients.
Herne K; Cirelli R; Lee P; Tyring SK
Drugs Aging; 1996 Feb; 8(2):97-112. PubMed ID: 8845591
[TBL] [Abstract][Full Text] [Related]
7. Aggregate health and economic burden of herpes zoster in the United States: illustrative example of a pain condition.
Harvey M; Prosser LA; Rose AM; Ortega-Sanchez IR; Harpaz R
Pain; 2020 Feb; 161(2):361-368. PubMed ID: 31599852
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness analysis of a vaccination program for the prevention of herpes zoster and post-herpetic neuralgia in adults aged 50 and over in Germany.
Préaud E; Uhart M; Böhm K; Aidelsburger P; Anger D; Bianic F; Largeron N
Hum Vaccin Immunother; 2015; 11(4):884-96. PubMed ID: 25933182
[TBL] [Abstract][Full Text] [Related]
9. Economic Burden of Herpes Zoster ("culebrilla") in Latin America.
Rampakakis E; Pollock C; Vujacich C; Toniolo Neto J; Ortiz Covarrubias A; Monsanto H; Johnson KD
Int J Infect Dis; 2017 May; 58():22-26. PubMed ID: 28267595
[TBL] [Abstract][Full Text] [Related]
10. Cost-Effectiveness of Herpes Zoster Vaccine for Persons Aged 50 Years.
Le P; Rothberg MB
Ann Intern Med; 2015 Oct; 163(7):489-97. PubMed ID: 26344036
[TBL] [Abstract][Full Text] [Related]
11. Willingness to pay for a QALY based on community member and patient preferences for temporary health states associated with herpes zoster.
Lieu TA; Ray GT; Ortega-Sanchez IR; Kleinman K; Rusinak D; Prosser LA
Pharmacoeconomics; 2009; 27(12):1005-16. PubMed ID: 19908925
[TBL] [Abstract][Full Text] [Related]
12. Current management of herpes zoster: the European view.
Volpi A; Gross G; Hercogova J; Johnson RW
Am J Clin Dermatol; 2005; 6(5):317-25. PubMed ID: 16252931
[TBL] [Abstract][Full Text] [Related]
13. Herpes zoster and postherpetic neuralgia. Optimal treatment.
Johnson RW
Drugs Aging; 1997 Feb; 10(2):80-94. PubMed ID: 9061266
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of low dose gabapentin in acute herpes zoster for preventing postherpetic neuralgia: a prospective controlled study.
Lee EG; Lee HJ; Hyun DJ; Min K; Kim DH; Yoon MS
Dermatol Ther; 2016 May; 29(3):184-90. PubMed ID: 26799145
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of famciclovir in the treatment of herpes zoster.
Tyring SK
Semin Dermatol; 1996 Jun; 15(2 Suppl 1):27-31. PubMed ID: 8840413
[TBL] [Abstract][Full Text] [Related]
16. Acute herpes zoster and post herpetic neuralgia in primary care: a study of diagnosis, treatment and cost.
Crosbie B; Lucey S; Tilson L; Domegan L; Kieran J
Eur J Clin Microbiol Infect Dis; 2018 Apr; 37(4):627-631. PubMed ID: 29218466
[TBL] [Abstract][Full Text] [Related]
17. [Neuralgia and zovirax treatment of patients with herpes zoster].
Dekonenko EP; Shishov AS; Kupriianova LV; Rudometov IuP; Bagrov FI
Ter Arkh; 1998; 70(12):63-5. PubMed ID: 10067257
[TBL] [Abstract][Full Text] [Related]
18. Herpes Zoster.
Schmader K
Clin Geriatr Med; 2016 Aug; 32(3):539-53. PubMed ID: 27394022
[TBL] [Abstract][Full Text] [Related]
19. Herpes zoster and postherpetic neuralgia.
Johnson RW
Expert Rev Vaccines; 2010 Mar; 9(3 Suppl):21-6. PubMed ID: 20192714
[TBL] [Abstract][Full Text] [Related]
20. Herpes zoster: diagnostic, therapeutic, and preventive approaches.
Bader MS
Postgrad Med; 2013 Sep; 125(5):78-91. PubMed ID: 24113666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
